Expediting Lung Cancer Diagnosis in Kenya

Situation For lung cancer patients in Kenya, receiving an initial diagnosis is only part of the diagnostic journey. Additional testing, including histology, immunohistochemistry and EGFR testing, may be required to determine the most appropriate treatment. For patients living outside Nairobi, completing these tests can create significant logistical and financial challenges. Tissue samples may need to … Continued

Eliminating Cash Flow Barriers to Expedite Lung Cancer Treatment

Situation According to the Kenya National Cancer Control Strategy 2017-2022, lung cancer accounted for 794 cases with 729 deaths and a prevalence of 1.75 per 100,000. This translates to a case fatality of 92 percent, ranking it 14th among all cancer types in the country. The financial burden of cancer treatment in Kenya is also … Continued